Scientists hunt for genes behind rare liver disease
NCT ID NCT01161953
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at the genetic makeup of 1,500 people with Primary Biliary Cirrhosis (PBC), a rare liver disease, along with their close relatives. By comparing genes, researchers hope to find inherited factors that make someone more likely to develop PBC. The goal is to better understand the disease and open doors to new ways to prevent, diagnose, or treat it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal which genes increase the risk of developing PBC, paving the way for earlier detection and new treatments.
- What could go wrong
- This is a genetic study, not a treatment trial. It may not directly lead to new therapies, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may tame the tightrope walk of transplant drugs
- Gut bacteria may hold key to liver disease mysteries
- Mayo clinic launches massive biobank to unlock secrets of rare liver diseases
- New hope for PBC patients: Long-Term safety trial of seladelpar underway
- New MRI scan could replace liver biopsies
- New hope for rare liver disease: drug shows promise in reducing damage and symptoms